These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11552774)

  • 21. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial.
    Tramontina S; Zeni CP; Pheula G; Rohde LA
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):129-34. PubMed ID: 17343561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN; Schwarzman LK; Hulihan JF; Xiang J; Rosenthal NR;
    J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
    Singh V; Bowden CL; Mintz J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expanding pharmacopoeia for bipolar disorder.
    Mitchell PB; Malhi GS
    Annu Rev Med; 2002; 53():173-88. PubMed ID: 11818469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate for acute affective episodes in bipolar disorder.
    Vasudev K; Macritchie K; Geddes J; Watson S; Young A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003384. PubMed ID: 16437453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamotrigine: a review of its use in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series.
    Kirov G; Tredget J
    BMC Psychiatry; 2005 Apr; 5():19. PubMed ID: 15817130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam.
    Gouliaev G; Licht RW; Vestergaard P; Merinder L; Lund H; Bjerre L
    Acta Psychiatr Scand; 1996 Feb; 93(2):119-24. PubMed ID: 8686481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania.
    Pavuluri MN; Janicak PG; Carbray J
    J Child Adolesc Psychopharmacol; 2002; 12(3):271-3. PubMed ID: 12427302
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute and maintenance treatment with mood stabilizers.
    Bowden CL
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):269-75. PubMed ID: 12974993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review.
    DelBello MP; Kowatch RA; Warner J; Schwiers ML; Rappaport KB; Daniels JP; Foster KD; Strakowski SM
    J Child Adolesc Psychopharmacol; 2002; 12(4):323-30. PubMed ID: 12625992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label study.
    Lykouras L; Hatzimanolis J
    Curr Med Res Opin; 2004 Jun; 20(6):843-7. PubMed ID: 15200741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New anticonvulsant medication uses in bipolar disorder.
    Wang PW; Ketter TA; Becker OV; Nowakowska C
    CNS Spectr; 2003 Dec; 8(12):930-2, 941-7. PubMed ID: 14978468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series.
    Roy Chengappa KN; Levine J; Rathore D; Parepally H; Atzert R
    Eur Psychiatry; 2001 Apr; 16(3):186-90. PubMed ID: 11353598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
    Chengappa KN; Chalasani L; Brar JS; Parepally H; Houck P; Levine J
    Clin Ther; 2002 Oct; 24(10):1576-84. PubMed ID: 12462287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.
    Macdonald KJ; Young LT
    CNS Drugs; 2002; 16(8):549-62. PubMed ID: 12096935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive topiramate treatment for a refractory familial adolescent mania.
    Lung FW; Liu CL; Wang CS; Tzeng DS
    World J Biol Psychiatry; 2009; 10(1):74-7. PubMed ID: 19673090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.